Clinical trial
A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral…
NCT00156078 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00156078 |
|---|---|
| Title | A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN) |
| Official title | A 14-Week, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study To Evaluate The Safety And Efficacy Of Pregabalin (150mg-600mg/Day) Using A Flexible Optimal Dose Schedule In Patients With Painful Diabetic Peripheral Neuropathy (DPN). |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetic Neuropathy, Painful |
| Intervention type | Drug |
| Interventions | pregabalin |
| Enrollment | 450 |
| Start date | Jan 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 25, 2021 |
| Countries | Argentina, Brazil, Chile, Colombia, Ecuador, Indonesia, Jordan, Lebanon, Malaysia, Mexico, Philippines, Saudi Arabia and 7 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: